A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors

NCT05678205 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Corporate business decision

Conditions

Breast Cancer
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: AB-201
DRUG: Cyclophosphamide
DRUG: Fludarabine

Sponsor

Artiva Biotherapeutics, Inc.